Lamotrigina Basi (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, reducing the influx of sodium ions during depolarisation. This stabilises neuronal membranes and limits the release of excitatory neurotransmitters such as glutamate, thereby decreasing seizure activity and mood swings.

The dose of lamotrigine is individualised by the prescribing clinician based on the patient’s age, weight, indication, and any concomitant medications. The prescriber determines the appropriate starting dose and titration schedule.

Safety data for lamotrigine in pregnancy and lactation are limited. Clinicians weigh the benefits of seizure or mood control against potential risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine is distinguished by its broad spectrum activity against both focal and generalized seizures and its mood‑stabilising properties, which many other antiepileptics lack. Compared with older agents such as carbamazepine, it has a lower risk of enzyme‑inducing drug interactions but requires careful titration to avoid skin reactions.

Lamotrigina Basi should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability.

Lamotrigina Basi is administered orally, usually as tablets or film‑coated tablets. The medication is taken with or without food, according to the prescriber’s instructions, and the dose is typically adjusted gradually to minimise the risk of rash.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood disorders like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts or behaviours. Immediate medical attention is required if any of these occur.

Lamotrigina Basi is contraindicated in patients with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for individuals with a history of severe skin reactions, significant liver disease, or those taking interacting medications that could markedly alter lamotrigine levels.